Vivimed Labs Ltd
NSE: VIVIMEDLAB BSE: 532660
₹6.72
(4.19%)
Sun, 31 May 2026, 07:23 pm
Market Cap548.06M
PE Ratio0
Dividend0
Health Technology
Pharmaceuticals: Major
24.5KVivimed Labs Cashflow
| Particulars | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Deprecation and amortization | -17.98M | -37.54M | -51.18M | -71.49M | -95.96M | -102.02M | -267.89M | -588.11M | -661.16M | -661.78M | -613.93M | -582.79M | -564.20M | -667.90M | -669.46M | -554.95M | -182.83M | -191.27M | -199.41M | -202.24M |
| Accumulated depreciation, total | -62.50M | -103.49M | -143.59M | -231.87M | -289.30M | -352.28M | -5.72B | -5.96B | -6.81B | -7.44B | -8.02B | -310.75M | -825.90M | -1.54B | -1.93B | -2.46B | -2.62B | -2.81B | -2.98B | -3.15B |
| Cash from operating activities | -35.84M | — | -42.93M | — | 551.28M | 103.89M | 167.97M | 2.89M | -1.41B | 836.37M | 1.14B | -79.15M | -580.61M | 3.55B | 206.09M | 5.13B | -122.20M | -189.40M | -278.99M | -40.97M |
| Funds from operations | 147.83M | 173.22M | 254.45M | — | 492.41M | 654.64M | 1.03B | 1.03B | 1.51B | 1.32B | 1.62B | 3.08B | 1.00B | 1.18B | -624.75M | 47.99M | -459.92M | -2.22B | -259.76M | -111.83M |
| Net income (cash flow) | 92.69M | 135.68M | 159.52M | 193.52M | 310.11M | 488.31M | 631.37M | 835.84M | 663.94M | 720.50M | 836.73M | 2.14B | 779.43M | 573.65M | -1.09B | -718.86M | -676.50M | -3.29B | -454.46M | -319.61M |
| Depreciation & amortization (cash flow) | 17.98M | — | 40.10M | — | 87.34M | 102.01M | 267.89M | 588.11M | 661.16M | 661.78M | 613.93M | 582.79M | 564.20M | 667.90M | 669.46M | 554.95M | 182.83M | 191.27M | 199.41M | 202.24M |
| Depreciation/depletion | 16.15M | — | 40.10M | — | 57.43M | 62.99M | 237.10M | 468.01M | 542.12M | 609.67M | 559.62M | 524.88M | 515.15M | 403.71M | 601.06M | 529.05M | 160.32M | 162.36M | 169.67M | 170.48M |
| Amortization | 1.82M | — | — | — | 29.91M | 39.02M | 30.79M | 120.10M | 119.04M | 52.11M | 54.31M | 57.91M | 49.05M | 264.19M | 68.40M | 25.90M | 22.51M | 28.91M | 29.74M | 31.76M |
| Deferred taxes (cash flow) | — | — | — | — | — | — | — | — | — | — | — | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-cash items | 806.00K | — | 958.00K | — | 8.62M | 0 | -12.94M | -534.32M | -14.84M | -116.97M | 6.92M | -367.29M | -420.57M | -149.88M | -199.46M | 250.70M | 0 | 892.80M | -940.00K | 910.00K |
| Changes in working capital | -183.67M | — | -297.38M | — | 58.87M | -550.75M | -865.13M | -1.03B | -2.92B | -483.81M | -477.49M | -3.16B | -1.58B | 2.37B | 830.84M | 5.09B | 337.72M | 2.03B | -19.23M | 70.86M |
| Cash from investing activities | -172.31M | — | -454.05M | — | -71.25M | -723.95M | -4.24B | -1.70B | -2.91B | -1.07B | -1.90B | -684.93M | -1.64B | -888.72M | -1.96B | 4.04B | -164.10M | -49.68M | 282.88M | -45.31M |
| Capital expenditures | -151.68M | — | -454.05M | — | -349.50M | -287.23M | -3.61B | -1.91B | -1.59B | -1.24B | -587.02M | -684.73M | -1.64B | -890.61M | -1.13B | 0 | -366.25M | -49.68M | -20.39M | -45.31M |
| Capital expenditures - fixed assets | -151.68M | — | -454.05M | — | -214.50M | -287.23M | -3.61B | -1.91B | -1.59B | -1.24B | -587.02M | -684.73M | -1.64B | -890.61M | -1.13B | — | -305.86M | -49.68M | -20.39M | -45.31M |
| Capital expenditures - other assets | 0 | — | 0 | — | -135.00M | — | — | — | — | — | — | — | — | — | — | 0 | -60.39M | — | — | — |
| Cash from financing activities | 212.29M | — | 602.30M | — | -593.57M | 674.81M | 4.33B | 1.57B | 4.43B | 151.70M | 804.42M | 1.01B | 2.65B | -2.71B | 1.31B | -9.61B | 293.81M | 204.80M | -21.24M | 73.10M |
| Free cash flow | -187.52M | — | -496.98M | — | 336.78M | -183.34M | -3.45B | -1.91B | -3.00B | -407.54M | 555.66M | -763.88M | -2.22B | 2.66B | -921.99M | — | -428.06M | -239.08M | -299.38M | -86.28M |